Failure of Vancomycin Continuous Infusion against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus

Continuous infusion of vancomycin was evaluated against experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA. Animals were infected with hVISA PC1 (vancomycin MIC, 2 mg/liter) or VISA PC3 (vancomycin MIC, 8 mg/liter) and treated for 5 days wit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Entenza, J. M., Veloso, T. R., Vouillamoz, J., Giddey, M., Moreillon, P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2011
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3019629/
https://ncbi.nlm.nih.gov/pubmed/20956604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00811-10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky